Kinsus Interconnect Technology (3189) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Feb, 2026Executive summary
Consolidated revenue for the six months ended June 30, 2025 was NT$18,183,470 thousand, up from NT$14,294,866 thousand year-over-year, driven by both IC substrate and optics segments.
Net income for the six-month period was NT$1,166,693 thousand, a significant increase from NT$814,014 thousand in the prior year period.
Earnings per share (EPS) for the six months were NT$1.35, up from NT$0.25 year-over-year.
Financial highlights
Gross profit margin for the six months was 22%, compared to 28% in the prior year period.
Operating income for the six months was NT$1,121,089 thousand, up from NT$676,581 thousand year-over-year.
Cash and cash equivalents as of June 30, 2025 were NT$13,227,433 thousand.
Total assets stood at NT$79,200,920 thousand, with total liabilities of NT$39,603,737 thousand.
Net cash provided by operating activities for the six months was NT$3,338,386 thousand.
Outlook and guidance
The company continues to invest in property, plant, and equipment, with NT$3,645,687 thousand spent in the first half of 2025.
Ongoing capital expenditures and long-term sales agreements are expected to support future growth.
Latest events from Kinsus Interconnect Technology
- Revenue and net income soared, driven by strong IC substrate and optics growth.3189
Q4 202523 Mar 2026 - Net income and revenue surged, led by Optics, with robust margins and ongoing capital investment.3189
Q2 202410 Feb 2026 - Strong profit growth and margin expansion, led by optics, with major capital investments.3189
Q3 202410 Feb 2026 - Revenue and net income rose over 13%, with major subsidiaries held for sale and stable dividends.3189
Q4 202410 Feb 2026 - Q1 2025 saw strong revenue and profit growth, with EPS at NT$0.61 and a NT$1.00 dividend approved.3189
Q1 202510 Feb 2026 - Strong revenue and profit growth, with a planned capital increase to fuel expansion.3189
Q3 202510 Feb 2026